The aim of this study was to test the relationship between depression and plasma concentrations of CCL2, CCL11, CX3CL1 and CXCL12 in mildly and moderately depressed primary-care patients, as well as the potential influence of an effective iCBT intervention on those molecules. The gene discussed is CCL2; the disease is major depressive disorder.